1. Home
  2. ARDX vs INMD Comparison

ARDX vs INMD Comparison

Compare ARDX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.42

Market Cap

975.9M

Sector

Health Care

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$14.36

Market Cap

857.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
INMD
Founded
2007
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
975.9M
857.4M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
ARDX
INMD
Price
$3.42
$14.36
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$15.14
$17.33
AVG Volume (30 Days)
3.9M
449.2K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,000.00
N/A
Revenue This Year
$37.75
$1.74
Revenue Next Year
$34.24
$3.26
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$12.72
52 Week High
$8.40
$16.74

Technical Indicators

Market Signals
Indicator
ARDX
INMD
Relative Strength Index (RSI) 24.11 29.79
Support Level N/A $14.19
Resistance Level $3.92 $14.60
Average True Range (ATR) 0.12 0.23
MACD 0.01 -0.05
Stochastic Oscillator 14.53 6.59

Price Performance

Historical Comparison
ARDX
INMD

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: